DAVITA INC.
DVAAPI behind this page
DVA FY 2025 request
Playground key active
/api/financials?ticker=DVA&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments | 1,911,083 | 1,496,580 | +27.7% |
| All Other Segments · Intersegment Elimination | -11,203 | -13,910 | +19.5% |
| Other Operating Segments With Intersegment · Operating Segments | 1,922,286 | 1,510,490 | +27.3% |
| US Dialysis And Related Lab Services | 11,731,986 | 11,318,970 | +3.6% |
| US Dialysis And Related Lab Services With Intersegment · Operating Segments | 11,792,944 | 11,390,717 | +3.5% |
| US Dialysis And Related Lab Services · Intersegment Elimination | -60,958 | -71,747 | +15.0% |
Show — breakouts |
|||
| Revenue | 13,643,069 | 12,815,550 | +6.5% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -72,161 | -85,657 | +15.8% |
| Operating Segments | 13,715,230 | 12,901,207 | +6.3% |
| Total Costs & Expenses (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 1,829,907 | 1,427,833 | +28.2% |
| US Dialysis And Related Lab Services · Operating Segments | 9,708,711 | 9,269,710 | +4.7% |
Show — breakouts |
|||
| Total Costs & Expenses | 11,599,454 | 10,725,067 | +8.2% |
| General & Administrative (FY) | — | — | — |
Show Business Segments breakouts |
|||
| US Dialysis And Related Lab Services · Operating Segments | 1,253,298 | 1,173,990 | +6.8% |
Show — breakouts |
|||
| General & Administrative | 1,673,630 | 1,538,341 | +8.8% |
| Operating Income (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 92,379 | 82,657 | +11.8% |
| US Dialysis And Related Lab Services · Operating Segments | 2,084,233 | 2,121,007 | -1.7% |
Show — breakouts |
|||
| Operating Income | 2,043,615 | 2,090,483 | -2.2% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,176,612 | 2,203,664 | -1.2% |
| Other Non-Operating Income (Expense) (FY) | — | — | — |
Show — breakouts |
|||
| Other Non-Operating Income (Expense) | -102,688 | -69,808 | -47.1% |
| Income Before Taxes (FY) | — | — | — |
Show — breakouts |
|||
| Income Before Taxes | 1,346,823 | 1,530,393 | -12.0% |
| Income Tax Expense (Benefit) (FY) | — | — | — |
Show — breakouts |
|||
| Income Tax Expense (Benefit) | 293,107 | 279,656 | +4.8% |
Show Statement Operating Activities Segment breakouts |
|||
| Segment Continuing Operations | 293,107 | 279,656 | +4.8% |
| Net Income (FY) | — | — | — |
Show — breakouts |
|||
| Net Income | 746,803 | 936,342 | -20.2% |
| Net Income (FY) | — | — | — |
Show — breakouts |
|||
| Net Income | 1,078,716 | 1,250,737 | -13.8% |
| Comprehensive Income (FY) | — | — | — |
Show — breakouts |
|||
| Comprehensive Income | 934,816 | 677,630 | +38.0% |
| EPS (Basic) (FY) | — | — | — |
Show — breakouts |
|||
| EPS (Basic) | 10.06 | 11.02 | -8.7% |
| EPS (Diluted) (FY) | — | — | — |
Show — breakouts |
|||
| EPS (Diluted) | 9.84 | 10.73 | -8.3% |
| Wtd Avg Shares (Basic) (FY) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Basic) | 74,227 | 84,991 | -12.7% |
| Wtd Avg Shares (Diluted) (FY) | — | — | — |
Show — breakouts |
|||
| Wtd Avg Shares (Diluted) | 75,885 | 87,274 | -13.0% |
| Depreciation And Amortization (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments | 81,952 | 62,679 | +30.7% |
| US Dialysis And Related Lab Services · Operating Segments | 633,396 | 661,181 | -4.2% |
Show — breakouts |
|||
| Depreciation And Amortization | 715,348 | 723,860 | -1.2% |
| Income Loss From Equity Method Investments (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 783 | -1,701 | +146.0% |
Show — breakouts |
|||
| Income Loss From Equity Method Investments | 33,000 | 26,189 | +26.0% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Equity Method Investments In Nonconsolidated Dialysis Partnerships | 33,000 | 26,189 | +26.0% |
| Net Income Loss Attributable To Noncontrolling Interest (FY) | — | — | — |
Show — breakouts |
|||
| Net Income Loss Attributable To Noncontrolling Interest | 331,913 | 314,395 | +5.6% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax (FY) | — | — | — |
Show — breakouts |
|||
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | -21,321 | 7,250 | -394.1% |
Show Derivative Instruments Gain Loss By Hedging Relationship breakouts |
|||
| Cash Flow Hedging | -21,321 | 7,250 | -394.1% |
| Revenue From Contract With Customer Including Assessed Tax (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 385,423 | 248,026 | +55.4% |
| All Other Segments · Other Government Payors | 914,387 | 717,735 | +27.4% |
| Other Operating Segments With Intersegment · Operating Segments | 1,299,810 | 965,761 | +34.6% |
| Other Operating Segments With Intersegment · Operating Segments | 11,203 | 13,910 | -19.5% |
| US Dialysis And Related Lab Services With Intersegment · Operating Segments | 11,768,334 | 11,366,361 | +3.5% |
| US Dialysis And Related Lab Services With Intersegment · Operating Segments | 11,707,376 | 11,294,614 | +3.7% |
| US Dialysis And Related Lab Services With Intersegment · Operating Segments | 60,958 | 71,747 | -15.0% |
| US Dialysis And Related Lab Services · Commercial Payors | 3,806,596 | 3,783,827 | +0.6% |
| US Dialysis And Related Lab Services · Medicaid and Managed Medicaid | 871,695 | 863,947 | +0.9% |
| US Dialysis And Related Lab Services · Medicare and Medicare Advantage | 6,740,392 | 6,374,882 | +5.7% |
| US Dialysis And Related Lab Services · Other Government Payors | 349,651 | 343,705 | +1.7% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 4,192,019 | 4,031,853 | +4.0% |
| Medicaid and Managed Medicaid | 871,695 | 863,947 | +0.9% |
| Medicare and Medicare Advantage | 6,740,392 | 6,374,882 | +5.7% |
| Other Government Payors | 1,264,038 | 1,061,440 | +19.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents (Q) | — | — | — |
Show — breakouts |
|||
| Cash & Cash Equivalents | 676,438 | 794,933 | -14.9% |
| Marketable Securities (Current) (Q) | — | — | — |
Show — breakouts |
|||
| Marketable Securities (Current) | 24,303 | 51,064 | -52.4% |
| Accounts Receivable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Receivable | 2,414,690 | 2,146,975 | +12.5% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Medicare | 881,191 | 768,536 | +14.7% |
| Inventory (Q) | — | — | — |
Show — breakouts |
|||
| Inventory | 160,627 | 134,559 | +19.4% |
| Prepaid Expenses & Other Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Prepaid Expenses & Other Current Assets | 156,285 | 122,948 | +27.1% |
| Total Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Assets | 4,058,003 | 3,746,072 | +8.3% |
| Non-Current Assets | |||
| Property, Plant & Equipment (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Non Us | 399,423 | 317,488 | +25.8% |
Show — breakouts |
|||
| Property, Plant & Equipment | 2,812,966 | 2,940,916 | -4.4% |
| Operating Lease Right-of-Use Assets (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Right-of-Use Assets | 2,397,179 | 2,393,558 | +0.2% |
| Goodwill (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments | 1,017,479 | 857,996 | +18.6% |
| US Dialysis And Related Lab Services | 6,527,616 | 6,517,220 | +0.2% |
Show — breakouts |
|||
| Goodwill | 7,545,095 | 7,375,216 | +2.3% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 71,684 | 349,069 | -79.5% |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Service Agreements | 45,025 | — | — |
| Other Non-Current Assets (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Assets | 246,520 | 261,731 | -5.8% |
| Marketable Securities (Non-Current) (Q) | — | — | — |
Show — breakouts |
|||
| Marketable Securities (Non-Current) | 40,966 | 33,660 | +21.7% |
| Total Assets (Q) | — | — | — |
Show — breakouts |
|||
| Total Assets | 17,480,103 | 17,285,268 | +1.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 640,481 | — | — |
| Current Liabilities | |||
| Accounts Payable (Q) | — | — | — |
Show — breakouts |
|||
| Accounts Payable | 696,148 | 547,200 | +27.2% |
| Total Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Current Liabilities | 3,141,634 | 2,973,410 | +5.7% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Operating Lease Liabilities | 2,175,658 | 2,209,655 | -1.5% |
| Deferred Tax Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Deferred Tax Liabilities | 756,869 | 665,361 | +13.8% |
| Other Non-Current Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Other Non-Current Liabilities | 83,516 | 169,588 | -50.8% |
| Total Liabilities (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities | 16,321,665 | 15,193,917 | +7.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 215,650 | — | — |
| Stockholders' Equity | |||
| Common Stock (Q) | — | — | — |
Show — breakouts |
|||
| Common Stock | 69 | 90 | -23.3% |
| Retained Earnings (Q) | — | — | — |
Show — breakouts |
|||
| Retained Earnings | -328,428 | 1,534,630 | -121.4% |
| Accumulated Other Comprehensive Income (Q) | — | — | — |
Show — breakouts |
|||
| Accumulated Other Comprehensive Income | -122,783 | -310,796 | +60.5% |
| Total Stockholders' Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Stockholders' Equity | -651,082 | 121,122 | -637.5% |
| Total Liabilities & Equity (Q) | — | — | — |
Show — breakouts |
|||
| Total Liabilities & Equity | 17,480,103 | 17,285,268 | +1.1% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization (FY) | — | — | — |
Show — breakouts |
|||
| Depreciation & Amortization | 708,252 | 716,396 | -1.1% |
| Stock-Based Compensation (FY) | — | — | — |
Show — breakouts |
|||
| Stock-Based Compensation | 139,953 | 102,788 | +36.2% |
| Deferred Income Taxes (FY) | — | — | — |
Show — breakouts |
|||
| Deferred Income Taxes | 86,574 | -57,840 | +249.7% |
| Other Non-Cash Items (FY) | — | — | — |
Show — breakouts |
|||
| Other Non-Cash Items | 17,549 | -13,414 | +230.8% |
| Change in Accounts Receivable (FY) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Receivable | 210,632 | 29,766 | +607.6% |
| Change in Inventory (FY) | — | — | — |
Show — breakouts |
|||
| Change in Inventory | 19,950 | -17,942 | +211.2% |
| Change in Accounts Payable (FY) | — | — | — |
Show — breakouts |
|||
| Change in Accounts Payable | 128,303 | 1,699 | +7451.7% |
| Change in Other Liabilities (FY) | — | — | — |
Show — breakouts |
|||
| Change in Other Liabilities | 7,348 | -6,672 | +210.1% |
| Net Cash from Operations (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Operations | 1,886,500 | 2,022,038 | -6.7% |
| Investing Activities | |||
| Capital Expenditures (FY) | — | — | — |
Show — breakouts |
|||
| Capital Expenditures | 575,864 | 555,443 | +3.7% |
| Net Cash from Investing (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Investing | -654,949 | -771,429 | +15.1% |
| Financing Activities | |||
| Share Repurchases (FY) | — | — | — |
Show — breakouts |
|||
| Share Repurchases | 1,308,366 | 1,385,932 | -5.6% |
| Tax Withholding for Share Compensation (FY) | — | — | — |
Show — breakouts |
|||
| Tax Withholding for Share Compensation | 35,291 | 134,040 | -73.7% |
| Amortization of Financing Costs (FY) | — | — | — |
Show — breakouts |
|||
| Amortization of Financing Costs | 40,002 | 35,266 | +13.4% |
| Net Cash from Financing (FY) | — | — | — |
Show — breakouts |
|||
| Net Cash from Financing | -1,374,780 | -816,937 | -68.3% |
| Supplemental | |||
| Income Taxes Paid (FY) | — | — | — |
Show — breakouts |
|||
| Income Taxes Paid | 176,688 | 387,940 | -54.5% |
| Interest Paid (FY) | — | — | — |
Show — breakouts |
|||
| Interest Paid | 515,497 | 423,360 | +21.8% |
| Other Cash Flow | |||
| Net Change in Cash (FY) | — | — | — |
Show — breakouts |
|||
| Net Change in Cash | -122,078 | 415,191 | -129.4% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.